SII vs. ABBV

Last updated Apr 1, 2026

Compare and contrast key facts about Sprott Inc (SII) and AbbVie Inc. (ABBV).

Performance

SII vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Sprott Inc (SII) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

SII vs. ABBV - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
SII Sprott Inc	46.30%	137.17%	27.39%	5.00%	-24.09%	59.43%	-11.70%
ABBV AbbVie Inc.	-4.05%	33.08%	18.86%	-0.23%	24.01%	32.43%	13.99%

Fundamentals

Market Cap SII : $2.68B ABBV : $385.83B
EPS SII : $4.19 ABBV : $2.38
PE Ratio SII : 34.09 ABBV : 91.23
PS Ratio SII : 8.41 ABBV : 6.30
Total Revenue (TTM) SII : $318.78M ABBV : $61.16B
Gross Profit (TTM) SII : $206.43M ABBV : $44.85B
EBITDA (TTM) SII : $109.60M ABBV : $28.29B

Returns By Period

In the year-to-date period, SII achieves a 46.30% return, which is significantly higher than ABBV's -4.05% return.

SII

• 1D: 6.68%
• 1M: -11.62%
• YTD: 46.30%
• 6M: 72.99%
• 1Y: 223.91%
• 3Y*: 61.57%
• 5Y*: 32.29%
• 10Y*: —

ABBV

• 1D: 2.05%
• 1M: -6.29%
• YTD: -4.05%
• 6M: -4.63%
• 1Y: 7.29%
• 3Y*: 15.00%
• 5Y*: 19.40%
• 10Y*: 19.07%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

SII vs. ABBV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

SII

SII Risk / Return Rank: 99
SII Sharpe Ratio Rank: 99
SII Sortino Ratio Rank: 99
SII Omega Ratio Rank: 98
SII Calmar Ratio Rank: 99
SII Martin Ratio Rank: 99

ABBV

ABBV Risk / Return Rank: 50
ABBV Sharpe Ratio Rank: 52
ABBV Sortino Ratio Rank: 44
ABBV Omega Ratio Rank: 44
ABBV Calmar Ratio Rank: 56
ABBV Martin Ratio Rank: 55

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

SII vs. ABBV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Sprott Inc (SII) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	SII	ABBV	Difference
Sharpe ratio Return per unit of total volatility	5.59	0.27	+5.32
Sortino ratio Return per unit of downside risk	5.08	0.54	+4.54
Omega ratio Gain probability vs. loss probability	1.70	1.07	+0.63
Calmar ratio Return relative to maximum drawdown	11.39	0.53	+10.86
Martin ratio Return relative to average drawdown	31.53	1.17	+30.36
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

SII vs. ABBV - Sharpe Ratio Comparison

The current SII Sharpe Ratio is 5.59, which is higher than the ABBV Sharpe Ratio of 0.27. The chart below compares the historical Sharpe Ratios of SII and ABBV, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	SII	ABBV	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	5.59	0.27	+5.32
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.91	0.86	+0.05
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	0.74	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.89	0.74	+0.15

Correlation

The correlation between SII and ABBV is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

SII vs. ABBV - Dividend Comparison

SII's dividend yield for the trailing twelve months is around 0.98%, less than ABBV's 3.06% yield.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
SII Sprott Inc	0.98%	1.33%	2.49%	2.95%	3.00%	2.22%	1.66%	0.00%	0.00%	0.00%	0.00%	0.00%
ABBV AbbVie Inc.	3.06%	2.87%	3.49%	3.82%	3.49%	3.84%	4.41%	4.83%	3.89%	2.65%	3.64%	3.41%

Drawdowns

SII vs. ABBV - Drawdown Comparison

The maximum SII drawdown since its inception was -47.81%, which is greater than ABBV's maximum drawdown of -45.09%. Use the drawdown chart below to compare losses from any high point for SII and ABBV.

Drawdown Indicators

	SII	ABBV	Difference
Max Drawdown Largest peak-to-trough decline	-47.81%	-45.09%	-2.72%
Max Drawdown (1Y) Largest decline over 1 year	-20.01%	-16.74%	-3.27%
Max Drawdown (5Y) Largest decline over 5 years	-47.81%	-21.92%	-25.89%
Max Drawdown (10Y) Largest decline over 10 years	—	-45.09%	—
Current Drawdown Current decline from peak	-14.12%	-9.64%	-4.48%
Average Drawdown Average peak-to-trough decline	-21.15%	-10.70%	-10.45%
Ulcer Index Depth and duration of drawdowns from previous peaks	7.23%	8.12%	-0.89%

Volatility

SII vs. ABBV - Volatility Comparison

Sprott Inc (SII) has a higher volatility of 15.47% compared to AbbVie Inc. (ABBV) at 7.57%. This indicates that SII's price experiences larger fluctuations and is considered to be riskier than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	SII	ABBV	Difference
Volatility (1M) Calculated over the trailing 1-month period	15.47%	7.57%	+7.90%
Volatility (6M) Calculated over the trailing 6-month period	33.31%	19.03%	+14.28%
Volatility (1Y) Calculated over the trailing 1-year period	40.34%	27.12%	+13.22%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	35.70%	22.61%	+13.09%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	36.17%	25.71%	+10.46%

Financials

SII vs. ABBV - Profitability Comparison

The chart below illustrates the profitability comparison between Sprott Inc and AbbVie Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

SII - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Sprott Inc reported a gross profit of 147.24M and revenue of 157.05M. Therefore, the gross margin over that period was 93.8%.

ABBV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, AbbVie Inc. reported a gross profit of 13.96B and revenue of 16.62B. Therefore, the gross margin over that period was 84.0%.

SII - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Sprott Inc reported an operating income of 55.66M and revenue of 157.05M, resulting in an operating margin of 35.4%.

ABBV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, AbbVie Inc. reported an operating income of 5.81B and revenue of 16.62B, resulting in an operating margin of 35.0%.

SII - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Sprott Inc reported a net income of 40.02M and revenue of 157.05M, resulting in a net margin of 25.5%.

ABBV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, AbbVie Inc. reported a net income of 1.82B and revenue of 16.62B, resulting in a net margin of 10.9%.